Muscle-Specific Pten Deletion Protects against Insulin Resistance and Diabetes

REFERENCES

• Backman, S., V. Stambolic, and T. Mak. 2002. Pten function in mammalian cell size regulation. Curr. Opin. Neurobiol. 12:516–522.
   PubMedGoogle Scholar
• Backman, S. A., D. Ghazarian, K. So, O. Sanchez, K. U. Wagner, L. Hennighausen, A. Suzuki, M. S. Tsao, W. B. Chapman, V. Stambolic, and T. W. Mak. 2004. Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc. Natl. Acad. Sci. USA 101:1725–1730.
   PubMed Web of Science ®Google Scholar
• Backman, S. A., V. Stambolic, A. Suzuki, J. Haight, A. Elia, J. Pretorius, M. S. Tsao, P. Shannon, B. Bolon, G. O. Ivy, and T. W. Mak. 2001. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29:396–403.
   PubMed Web of Science ®Google Scholar
• Bruning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Horsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559–569.
   PubMed Web of Science ®Google Scholar
• Butler, M., R. A. McKay, I. J. Popoff, W. A. Gaarde, D. Witchell, S. F. Murray, N. M. Dean, S. Bhanot, and B. P. Monia. 2002. Specific inhibition of Pten expression reverses hyperglycemia in diabetic mice. Diabetes 51:1028–1034.
   PubMed Web of Science ®Google Scholar
• Cheatham, B., C. J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C. R. Kahn. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902–4911.
   PubMed Web of Science ®Google Scholar
• Cheng, A., N. Uetani, P. D. Simoncic, V. P. Chaubey, A. Lee-Loy, C. J. McGlade, B. P. Kennedy, and M. L. Tremblay. 2002. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell 2:497–503.
   PubMed Web of Science ®Google Scholar
• Cho, H., J. Mu, J. K. Kim, J. L. Thorvaldsen, Q. Chu, E. B. Crenshaw III, K. H. Kaestner, M. S. Bartolomei, G. I. Shulman, and M. J. Birnbaum. 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728–1731.
   PubMed Web of Science ®Google Scholar
• Clement, S., U. Krause, F. Desmedt, J. F. Tanti, J. Behrends, X. Pesesse, T. Sasaki, J. Penninger, M. Doherty, W. Malaisse, J. E. Dumont, Y. Le Marchand-Brustel, C. Erneux, L. Hue, and S. Schurmans. 2001. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409:92–97.
   PubMed Web of Science ®Google Scholar
• Crackower, M. A., G. Y. Oudit, I. Kozieradzki, R. Sarao, H. Sun, T. Sasaki, E. Hirsch, A. Suzuki, T. Shioi, J. Irie-Sasaki, R. Sah, H. Y. Cheng, V. O. Rybin, G. Lembo, L. Fratta, A. J. Oliveira-dos-Santos, J. L. Benovic, C. R. Kahn, S. Izumo, S. F. Steinberg, M. P. Wymann, P. H. Backx, and J. M. Penninger. 2002. Regulation of myocardial contractility and cell size by distinct PI3K-Pten signaling pathways. Cell 110:737–749.
   PubMed Web of Science ®Google Scholar
• DeFronzo, R. A., R. Gunnarsson, O. Bjorkman, M. Olsson, and J. Wahren. 1985. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J. Clin. Investig. 76:149–155.
   PubMed Web of Science ®Google Scholar
• Fink, R. I., P. Wallace, and J. M. Olefsky. 1986. Effects of aging on glucose-mediated glucose disposal and glucose transport. J. Clin. Investig. 77:2034–2041.
   PubMedGoogle Scholar
• Gil, E. B., E. Malone Link, L. X. Liu, C. D. Johnson, and J. A. Lees. 1999. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the Pten tumor suppressor gene. Proc. Natl. Acad. Sci. USA 96:2925–2930.
   PubMedGoogle Scholar
• Hara, K., K. Yonezawa, H. Sakaue, A. Ando, K. Kotani, T. Kitamura, Y. Kitamura, H. Ueda, L. Stephens, T. R. Jackson, et al. 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA 91:7415–7419.
   PubMed Web of Science ®Google Scholar
• Horie, Y., A. Suzuki, E. Kataoka, T. Sasaki, K. Hamada, J. Sasaki, K. Mizuno, G. Hasegawa, H. Kishimoto, M. Iizuka, M. Naito, K. Enomoto, S. Watanabe, T. W. Mak, and T. Nakano. 2004. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Investig. 113:1774–1783.
   PubMed Web of Science ®Google Scholar
• Ishihara, H., T. Sasaoka, S. Kagawa, S. Murakami, K. Fukui, Y. Kawagishi, K. Yamazaki, A. Sato, M. Iwata, M. Urakaze, M. Ishiki, T. Wada, S. Yaguchi, H. Tsuneki, I. Kimura, and M. Kobayashi. 2003. Association of the polymorphisms in the 5′-untranslated region of Pten gene with type 2 diabetes in a Japanese population. FEBS Lett. 554:450–454.
   PubMed Web of Science ®Google Scholar
• Jiang, Z. Y., Q. L. Zhou, K. A. Coleman, M. Chouinard, Q. Boese, and M. P. Czech. 2003. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA 100:7569–7574.
   PubMed Web of Science ®Google Scholar
• Kahn, C. R. 2003. Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes. Exp. Diabesity Res. 4:169–182.
   PubMedGoogle Scholar
• Katagiri, H., T. Asano, H. Ishihara, K. Inukai, Y. Shibasaki, M. Kikuchi, Y. Yazaki, and Y. Oka. 1996. Overexpression of catalytic subunit p110alpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J. Biol. Chem. 271:16987–16990.
   PubMed Web of Science ®Google Scholar
• Katome, T., T. Obata, R. Matsushima, N. Masuyama, L. C. Cantley, Y. Gotoh, K. Kishi, H. Shiota, and Y. Ebina. 2003. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J. Biol. Chem. 278:28312–28323.
   PubMed Web of Science ®Google Scholar
• Kishimoto, H., K. Hamada, M. Saunders, S. Backman, T. Sasaki, T. Nakano, T. W. Mak, and A. Suzuki. 2003. Physiological functions of Pten in mouse tissues. Cell Struct. Funct. 28:11–21.
   PubMedGoogle Scholar
• Kitamura, T., C. R. Kahn, and D. Accili. 2003. Insulin receptor knockout mice. Annu. Rev. Physiol. 65:313–332.
   PubMed Web of Science ®Google Scholar
• Kruszynska, Y. T., and J. M. Olefsky. 1996. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J. Investig. Med. 44:413–428.
   PubMed Web of Science ®Google Scholar
• Li, J., C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler, and R. Parsons. 1997. Pten, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947.
   PubMed Web of Science ®Google Scholar
• Lillioja, S., A. A. Young, C. L. Culter, J. L. Ivy, W. G. Abbott, J. K. Zawadzki, H. Yki-Jarvinen, L. Christin, T. W. Secomb, and C. Bogardus. 1987. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J. Clin. Investig. 80:415–424.
   PubMed Web of Science ®Google Scholar
• Mauvais-Jarvis, F., R. N. Kulkarni, and C. R. Kahn. 2002. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin. Endocrinol. 57:1–9.
   PubMedGoogle Scholar
• Mihaylova, V. T., C. Z. Borland, L. Manjarrez, M. J. Stern, and H. Sun. 1999. The Pten tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc. Natl. Acad. Sci. USA 96:7427–7432.
   PubMedGoogle Scholar
• Miles, P. D., Y. Barak, R. M. Evans, and J. M. Olefsky. 2003. Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding. Am. J. Physiol. Endocrinol. Metab. 284:E618–E626.
   PubMedGoogle Scholar
• Nakashima, N., P. M. Sharma, T. Imamura, R. Bookstein, and J. M. Olefsky. 2000. The tumor suppressor Pten negatively regulates insulin signaling in 3T3-L1 adipocytes. J. Biol. Chem. 275:12889–12895.
   PubMed Web of Science ®Google Scholar
• Ogg, S., and G. Ruvkun. 1998. The C. elegans Pten homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol. Cell 2:887–893.
   PubMed Web of Science ®Google Scholar
• Ono, H., H. Katagiri, M. Funaki, M. Anai, K. Inukai, Y. Fukushima, H. Sakoda, T. Ogihara, Y. Onishi, M. Fujishiro, M. Kikuchi, Y. Oka, and T. Asano. 2001. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by Pten (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Mol. Endocrinol. 15:1411–1422.
   PubMed Web of Science ®Google Scholar
• Petersen, K. F., D. Befroy, S. Dufour, J. Dziura, C. Ariyan, D. L. Rothman, L. DiPietro, G. W. Cline, and G. I. Shulman. 2003. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142.
   PubMed Web of Science ®Google Scholar
• Rudich, A., D. Konrad, D. Torok, R. Ben-Romano, C. Huang, W. Niu, R. R. Garg, N. Wijesekara, R. J. Germinario, P. J. Bilan, and A. Klip. 2003. Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues. Diabetologia 46:649–658.
   PubMed Web of Science ®Google Scholar
• Scheid, M. P., and J. R. Woodgett. 2001. PKB/AKT: functional insights from genetic models. Nat. Rev. Mol. Cell. Biol. 2:760–768.
   PubMed Web of Science ®Google Scholar
• Somwar, R., M. Perreault, S. Kapur, C. Taha, G. Sweeney, T. Ramlal, D. Y. Kim, J. Keen, C. H. Cote, A. Klip, and A. Marette. 2000. Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport. Diabetes 49:1794–1800.
   PubMed Web of Science ®Google Scholar
• Song, X. M., J. W. Ryder, Y. Kawano, A. V. Chibalin, A. Krook, and J. R. Zierath. 1999. Muscle fiber type specificity in insulin signal transduction. Am. J. Physiol. 277:R1690–R1696.
   PubMedGoogle Scholar
• Stambolic, V., A. Suzuki, J. L. de la Pompa, G. M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J. M. Penninger, D. P. Siderovski, and T. W. Mak. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor Pten. Cell 95:29–39.
   PubMed Web of Science ®Google Scholar
• Stambolic, V., M. S. Tsao, D. Macpherson, A. Suzuki, W. B. Chapman, and T. W. Mak. 2000. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res. 60:3605–3611.
   PubMed Web of Science ®Google Scholar
• Steck, P. A., M. A. Pershouse, S. A. Jasser, W. K. Yung, H. Lin, A. H. Ligon, L. A. Langford, M. L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D. H. Teng, and S. V. Tavtigian. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15:356–362.
   PubMed Web of Science ®Google Scholar
• Stiles, B., Y. Wang, A. Stahl, S. Bassilian, W. P. Lee, Y. J. Kim, R. Sherwin, S. Devaskar, R. Lesche, M. A. Magnuson, and H. Wu. 2004. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proc. Natl. Acad. Sci. USA 101:2082–2087. (Erratum, 101:5180.)
   PubMed Web of Science ®Google Scholar
• Suzuki, A., J. L. de la Pompa, V. Stambolic, A. J. Elia, T. Sasaki, I. del Barco Barrantes, A. Ho, A. Wakeham, A. Itie, W. Khoo, M. Fukumoto, and T. W. Mak. 1998. High cancer susceptibility and embryonic lethality associated with mutation of the Pten tumor suppressor gene in mice. Curr. Biol. 8:1169–1178.
   PubMed Web of Science ®Google Scholar
• Suzuki, A., S. Itami, M. Ohishi, K. Hamada, T. Inoue, N. Komazawa, H. Senoo, T. Sasaki, J. Takeda, M. Manabe, T. W. Mak, and T. Nakano. 2003. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res. 63:674–681.
   PubMedGoogle Scholar
• Suzuki, A., T. Kaisho, M. Ohishi, M. Tsukio-Yamaguchi, T. Tsubata, P. A. Koni, T. Sasaki, T. W. Mak, and T. Nakano. 2003. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J. Exp. Med. 197:657–667.
   PubMed Web of Science ®Google Scholar
• Tanti, J. F., T. Gremeaux, S. Grillo, V. Calleja, A. Klippel, L. T. Williams, E. Van Obberghen, and Y. Le Marchand-Brustel. 1996. Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J. Biol. Chem. 271:25227–25232.
   PubMed Web of Science ®Google Scholar
• Totsuka, Y., Y. Nagao, T. Horii, H. Yonekawa, H. Imai, H. Hatta, Y. Izaike, T. Tokunaga, and Y. Atomi. 2003. Physical performance and soleus muscle fiber composition in wild-derived and laboratory inbred mouse strains. J. Appl. Physiol. 95:720–727.
   PubMedGoogle Scholar
• Tsakiridis, T., M. Vranic, and A. Klip. 1994. Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J. Biol. Chem. 269:29934–29942.
   PubMed Web of Science ®Google Scholar
• Vaag, A., J. E. Henriksen, and H. Beck-Nielsen. 1992. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Investig. 89:782–788.
   PubMed Web of Science ®Google Scholar
• Wang, Q., R. Somwar, P. J. Bilan, Z. Liu, J. Jin, J. R. Woodgett, and A. Klip. 1999. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19:4008–4018.
   PubMed Web of Science ®Google Scholar
• Zabolotny, J. M., K. K. Bence-Hanulec, A. Stricker-Krongrad, F. Haj, Y. Wang, Y. Minokoshi, Y. B. Kim, J. K. Elmquist, L. A. Tartaglia, B. B. Kahn, and B. G. Neel. 2002. PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2:489–495.
   PubMed Web of Science ®Google Scholar
• Zierath, J. R., K. L. Houseknecht, L. Gnudi, and B. B. Kahn. 1997. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 46:215–223.
   PubMed Web of Science ®Google Scholar
• Zisman, A., O. D. Peroni, E. D. Abel, M. D. Michael, F. Mauvais-Jarvis, B. B. Lowell, J. F. Wojtaszewski, M. F. Hirshman, A. Virkamaki, L. J. Goodyear, C. R. Kahn, and B. B. Kahn. 2000. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6:924–928.
   PubMed Web of Science ®Google Scholar